Advertisement

Advertisement

PULM Stock Latest News

Pulmatrix Raises $1M in Preferred Stock Financing

Company AnnouncementsPulmatrix Raises $1M in Preferred Stock Financing

Pulmatrix to Merge With Eos SENOLYTIX, Rebrand on Nasdaq

PremiumCompany Announcements

Pulmatrix to Merge With Eos SENOLYTIX, Rebrand on Nasdaq

1M ago

Pulmatrix to merge with Eos Senolytix

PremiumThe Fly

Pulmatrix to merge with Eos Senolytix

1M ago

Pulmatrix Pursues New Reverse Merger After Cullgen Termination

PremiumCompany Announcements

Pulmatrix Pursues New Reverse Merger After Cullgen Termination

2M ago

Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction

PremiumThe Fly

Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction

2M ago

Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction

PremiumThe FlyGyre Therapeutics to acquire Cullgen in $300M all-stock transaction

2M ago

Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction

The Fly

Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction

2M ago

Pulmatrix announces Cullgen terminates merger agreement

The Fly

Pulmatrix announces Cullgen terminates merger agreement

2M ago

Pulmatrix and Cullgen Suspend No-Solicitation to Seek Alternatives

PremiumCompany Announcements

Pulmatrix and Cullgen Suspend No-Solicitation to Seek Alternatives

4M ago

Pulmatrix and Cullgen continue to pursue merger

PremiumThe Fly

Pulmatrix and Cullgen continue to pursue merger

4M ago

Pulmatrix Reports Q3 2025 Results and Strategic Shift

PremiumCompany Announcements

Pulmatrix Reports Q3 2025 Results and Strategic Shift

6M ago

Pulmatrix reports Q3 EPS (24c) vs. (71c) last year

PremiumThe Fly

Pulmatrix reports Q3 EPS (24c) vs. (71c) last year

6M ago

Pulmatrix to potentially divest its patent portfolio for iSPERSE technology

PremiumThe FlyPulmatrix to potentially divest its patent portfolio for iSPERSE technology

6M ago

Pulmatrix Reports Q2 2025 Results and Merger Plans

Company Announcements

Pulmatrix Reports Q2 2025 Results and Merger Plans

8M ago

Pulmatrix to potentially divest its patent portfolio for iSPERSE technology

The Fly

Pulmatrix to potentially divest its patent portfolio for iSPERSE technology

9M ago

Pulmatrix trading resumes

PremiumThe Fly

Pulmatrix trading resumes

10M ago

Pulmatrix trading halted, volatility trading pause

PremiumThe Fly

Pulmatrix trading halted, volatility trading pause

10M ago

Pulmatrix trading halted, volatility trading pause

PremiumThe Fly

Pulmatrix trading halted, volatility trading pause

10M ago

Pulmatrix trading resumes

PremiumThe Fly

Pulmatrix trading resumes

10M ago

Pulmatrix Stockholders Approve Merger with Cullgen

PremiumCompany AnnouncementsPulmatrix Stockholders Approve Merger with Cullgen

11M ago

Pulmatrix Reports 2024 Financials and Merger Plans

Company Announcements

Pulmatrix Reports 2024 Financials and Merger Plans

1y ago

Cullgen begins Phase 1 dosing of oral, pan-TRK protein degrader

The Fly

Cullgen begins Phase 1 dosing of oral, pan-TRK protein degrader

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >